MARY MATTEI: Open Payments
NPI 1619251568 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,807 in 100 payments from 30 companies in 2025. Trend: 2023 $2,211 · 2024 $2,349 · 2025 $1,807
Food & beverage: $1,807
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 11 | $203 |
| Merck Sharp & Dohme LLC | 13 | $181 |
| Janssen Biotech, Inc. | 10 | $141 |
| TerSera Therapeutics LLC | 5 | $115 |
| Incyte Corporation | 5 | $112 |
| PFIZER INC. | 4 | $108 |
| Novartis Pharmaceuticals Corporation | 5 | $95 |
| Genentech USA, Inc. | 5 | $95 |
| GlaxoSmithKline, LLC. | 5 | $94 |
| AstraZeneca Pharmaceuticals LP | 5 | $93 |
Products named: KEYTRUDA, Enhertu, JEMPERLI, ERLEADA, MONJUVI, DATROWAY, Lenvima, XYNTHA.
Industry payments across AL — which companies pay providers there.
